113 results
Page 2 of 6
FWP
h0c9romodnn1i1sm
5 Oct 23
Free writing prospectus
5:05pm
FWP
2d3og79 3mg
3 Oct 23
Free writing prospectus
5:47pm
8-K
EX-10.1
bbj u9w9e20t
8 Sep 23
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
dr2j8ceejyor
10 Aug 23
Avenue Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
4:20pm
8-K
abk44hsibao na7ga
21 Jul 23
Other Events
4:37pm
424B3
8m6bh2oztev7 vp1
28 Jun 23
Prospectus supplement
4:56pm
8-K
bx5ox8w549d6m4pdj4db
22 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
EX-99.1
5wzm7txf 2dgvo
12 May 23
Avenue Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
8:35am
424B3
xliso
4 May 23
Prospectus supplement
4:30pm
8-K
EX-99.1
wfp abzqchsx4l61ygfi
17 Apr 23
Avenue Therapeutics Announces Regulatory Update Based on Type C Meeting with FDA and Next Steps in the Development of IV Tramadol
4:06pm